Neurokinin Receptor Antagonist Associated to Ondansetron in PONV

NCT02357693 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG: Aprepitant

Sponsor

Instituto do Cancer do Estado de São Paulo